ReviewJournal of hematology & oncology2022

Small-molecule inhibitors, immune checkpoint inhibitors, and more: FDA-approved novel therapeutic drugs for solid tumors from 1991 to 2021.

Qing Wu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.